This inventor holds 1 USPTO granted patent. Top assignee: Kaneka Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Junya Akagi in Protein Engineering
Introduction
Junya Akagi is a notable inventor based in Hyogo, Japan, recognized for his contributions to protein engineering. His work primarily focuses on developing novel proteins with enhanced properties for immunoglobulin binding. With a keen interest in improving the stability and efficiency of these proteins, Akagi has made significant strides in the field.
Latest Patents
One of Akagi's key patents is titled "Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand." This invention aims to create a novel engineered Protein A ligand that exhibits superior antibody dissociation properties in acidic conditions compared to conventional ligands. Additionally, it seeks to enhance the alkali resistance of the engineered Protein A ligand. The patent describes a protein with an amino acid sequence derived from the E, D, A, B, and C domains of Protein A, where at least one Gly residue is replaced with an amino acid other than Ala. This modification results in a protein that has a lower affinity for the Fab region of an immunoglobulin than its counterparts.
Career Highlights
Junya Akagi is associated with Kaneka Corporation, where he continues to innovate and develop new technologies in protein engineering. His work has garnered attention for its potential applications in various fields, including biotechnology and pharmaceuticals.
Collaborations
Throughout his career, Akagi has collaborated with esteemed colleagues such as Shinichi Yoshida and Yoshiyuki Nakano. These collaborations have contributed to the advancement of research and development in protein engineering.
Conclusion
Junya Akagi's innovative work in protein engineering, particularly his patented developments, showcases his commitment to advancing the field. His contributions are poised to have a lasting impact on the biotechnology industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
